{"meshTagsMajor":["Esophagogastric Junction"],"meshTags":["Receptor, Epidermal Growth Factor","Esophageal Neoplasms","Quinazolines","Proto-Oncogene Proteins c-akt","Erlotinib Hydrochloride","Immunohistochemistry","Phosphorylation","Treatment Outcome","Stomach Neoplasms","Protein Kinase Inhibitors","In Situ Hybridization, Fluorescence","Esophagogastric Junction","Humans"],"meshMinor":["Receptor, Epidermal Growth Factor","Esophageal Neoplasms","Quinazolines","Proto-Oncogene Proteins c-akt","Erlotinib Hydrochloride","Immunohistochemistry","Phosphorylation","Treatment Outcome","Stomach Neoplasms","Protein Kinase Inhibitors","In Situ Hybridization, Fluorescence","Humans"],"genes":["epidermal growth factor receptor"],"publicationTypes":["Comment","Letter"],"title":"Outcome prediction to erlotinib in gastroesophageal adenocarcinomas: can we improve epidermal growth factor receptor and phospho-AKT testing?","pubmedId":"17327617"}